Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Watch & Wait”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Not applicableNot Yet RecruitingNCT07410715
What this trial is testing

Surgery vs. Watch-and-Wait Strategy in Complete Responders for Hepatocellular Carcinoma (SWITCH)

Who this might be right for
HCC - Hepatocellular CarcinomaWatch & WaitSurgery
West China Hospital 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06390982
What this trial is testing

Organ Preservation With Tislelizumab and Total Neoadjuvant Therapy in Patients With Low Rectal Cancer: RELIEVE -01 Study

Who this might be right for
RECTAL NEOPLASMSRectal Cancer
Fudan University 46
Testing effectiveness (Phase 2)Study completedNCT04696757
What this trial is testing

Non-OpeRative MANagement of Rectal Cancer Patients

Who this might be right for
Rectal CancerChemoradiotherapyWatch & Wait
Kangbuk Samsung Hospital 18
Large-scale testing (Phase 3)UnknownNCT05081687
What this trial is testing

Brazilian Total Neoadjuvant Therapy Trial

Who this might be right for
Colorectal Neoplasms
Hospital Israelita Albert Einstein 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06686381
What this trial is testing

Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W

Who this might be right for
Muscle-invasive Bladder Cancer
American University of Beirut Medical Center 80
Testing effectiveness (Phase 2)Study completedNCT04009876
What this trial is testing

Evaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
Fundación de investigación HM 30
Not applicableLooking for participantsNCT06477991
What this trial is testing

The Efficacy of Watch and Wait Strategy or Surgery After Neoadjuvant Immunotherapy for Locally Advanced Colorectal Cancer With dMMR/MSI-H Guided by MRD Dynamic Monitoring: A Single-center, Open-label, Prospective, Phase II Clinical Trial.

Who this might be right for
Clinical Complete Response Rate With Negative MRD
Yunnan Cancer Hospital 22
Testing effectiveness (Phase 2)Looking for participantsNCT06812728
What this trial is testing

Neoadjuvant FOLFIRINOX and Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer Patients

Who this might be right for
Rectum Cancer
Menoufia University 100
Not applicableLooking for participantsNCT03125343
What this trial is testing

Watch and Wait as Treatment for Patients With Rectal Cancer

Who this might be right for
Rectal Neoplasms
Sahlgrenska University Hospital 400
Not applicableWithdrawnNCT07292285
What this trial is testing

The Surveillance Nonoperative Watch & Wait (SNOWW) Rectal Cancer Trial.

Who this might be right for
Cancer of the Rectum
University of Colorado, Denver
Not applicableEnded earlyNCT03402477
What this trial is testing

"Watch and Wait" After Neo-adjuvant Chemoradiotherapy for Primary Locally Advanced Rectal Cancer.

Who this might be right for
Rectal Cancer
Helse Stavanger HF 86
Not applicableLooking for participantsNCT04743102
What this trial is testing

Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal Cancer

Who this might be right for
Rectal CancerNeoadjuvant TherapyComplete Remission+1 more
Beijing Chao Yang Hospital 260
Testing effectiveness (Phase 2)Looking for participantsNCT05939661
What this trial is testing

Single-arm P2 to Evaluate Safety and Efficacy of the Total Neoadjuvant Therapy for cT2 Rectal Cancer

Who this might be right for
Rectal Cancer
Osaka University 45
Testing effectiveness (Phase 2)Looking for participantsNCT06059495
What this trial is testing

Watch-and-Wait Approach With Dostarlimab in Localized dMMR/MSI-H Gastric Cancer: GERCOR Phase II Study

Who this might be right for
Adenocarcinoma - GEJGastric Adenocarcinoma
GERCOR - Multidisciplinary Oncology Cooperative Group 59
Not applicableLooking for participantsNCT07260526
What this trial is testing

Response-adapted Total Neoadjuvant Therapy Guided by Induction Chemotherapy in Early- and Intermediate-risk Low Rectal Cancer for Implementation of a Watch-and-wait Strategy

Who this might be right for
Rectal Cancer
West China Hospital 60
Not applicableTemporarily pausedNCT04336202
What this trial is testing

Watch and Wait Management on Rectal Cancer Patients Using New Swift Local Therapy

Who this might be right for
Rectal CancerComorbidities and Coexisting ConditionsInoperable Disease+1 more
Sir Mortimer B. Davis - Jewish General Hospital 45
Not applicableUnknownNCT04095468
What this trial is testing

Organ-preserving Management in Patients With Complete or Near-complete Tumour Response After Preoperative Radio(Chemo)Therapy for Rectal Cancer

Who this might be right for
Rectal NeoplasmsRectal Cancer
Maria Sklodowska-Curie National Research Institute of Oncology 215
Not applicableUnknownNCT03426397
What this trial is testing

"Wait-and-see" Policy for Complete Responders After Chemoradiotherapy for Rectal Cancer

Who this might be right for
Rectal Neoplasms
The Netherlands Cancer Institute 220
Not applicableStudy completedNCT02298855
What this trial is testing

Individualised Versus Conventional Medical Follow-up for Women After Primary Treatment for Ovarian Cancer.

Who this might be right for
Ovarian Cancer
University College, London 113
Not applicableNot Yet RecruitingNCT07088484
What this trial is testing

Watch-and-Wait After Immunochemotherapy in Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Recurrent Nasopharyngeal Carcinoma
Fujian Cancer Hospital 50
Load More Results